Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Cormedix Inc. (CRMD)  
$5.25 0.08 (1.5%) as of 4:30 Wed 5/15


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 32,130,000
Market Cap: 168.68(M)
Last Volume: 33,837 Avg Vol: 33,743
52 Week Range: $2.94 - $6.39
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 5.8
Insider 6 Months    : 7.8
Insider 3/6 Months : 14
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. Co.'s primary focus is on the development of its primary product candidate, DefenCath™, for potential commercialization in the U.S. and other main markets. Co. has in-licensed the worldwide rights to develop and commercialize DefenCath and Neutrolin®. DefenCath/Neutrolin is an anti-infective solution intended for the reduction of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as hemodialysis and total parenteral nutrition.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 13,561 20,561 64,561 104,261
Total Buy Value $50,718 $74,968 $265,441 $412,965
Total People Bought 1 3 6 6
Total Buy Transactions 1 4 10 14
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 260
  Page 8 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-05-13 4 S $2.58 $105,130 D/D (40,000) 20,000     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2016-05-13 4 OE $0.68 $40,800 D/D 60,000 60,000     -
   Lefkowitz Steven W Director   –       •      –    2016-02-04 4 OE $0.29 $8,700 D/D 30,000 147,399     -
   Dillione Janet Director   •       •      –    2015-09-22 4 B $2.66 $39,900 D/D 15,000 15,000 2.81     -
   Milby Randy Chief Executive Officer   •       •      –    2015-06-30 4 B $3.88 $6,247 D/D 1,610 57,026 2.81     -
   Markvicka Taunia Director   –       •      –    2015-06-23 4 B $4.81 $19,240 D/D 4,000 4,000 2.39     -
   Milby Randy Chief Executive Officer   •       •      –    2015-06-15 4 B $5.02 $6,250 D/D 1,245 55,416 2.81     -
   Duffy Matthew Director   –       •      –    2015-06-04 4 S $6.48 $194,412 D/D (30,000) 53,223     -
   Duffy Matthew Director   –       •      –    2015-06-02 4 OE $0.28 $11,450 D/D 40,000 83,223     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2015-06-01 4 S $6.37 $191,052 D/D (30,000) 0     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2015-06-01 4 OE $0.29 $8,700 D/D 30,000 30,000     -
   Lefkowitz Steven W Director   –       •      –    2015-06-01 4 S $6.66 $193,497 D/D (29,072) 117,399     -
   Milby Randy Chief Executive Officer   •       •      –    2015-05-29 4 B $6.09 $6,248 D/D 1,026 54,171 2.81     -
   Lefkowitz Steven W Director   –       •      –    2015-05-28 4 S $6.16 $61,602 D/D (10,000) 146,471     -
   Milby Randy Chief Executive Officer   •       •      –    2015-05-15 4 B $6.38 $6,246 D/D 979 53,145 2.81     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2015-05-14 4 S $6.49 $77,875 D/D (12,003) 0     -
   Pfaffle Antony Interim Chief Medical Officer   •       •      –    2015-05-13 4 S $6.49 $30,668 D/D (4,722) 12,003     -
   Duffy Matthew Director   –       •      –    2015-04-30 4 OE $3.44 $16,789 D/D 4,884 43,223     -
   Lefkowitz Steven W Director   –       •      –    2015-04-23 4 OE $3.44 $111,499 D/D 32,436 156,471     -
   Milby Randy Chief Executive Officer   •       •      –    2015-04-15 4 B $8.55 $6,242 D/D 730 52,166 2.81     -
   Tellez Cora M Director   –       •      –    2015-03-31 4 OE $0.90 $22,500 D/D 25,000 88,386     -
   Milby Randy Chief Executive Officer   •       •      –    2015-02-27 4 B $5.16 $6,249 D/D 1,211 51,436 2.81     -
   Milby Randy Chief Executive Officer   •       •      –    2015-02-13 4 B $3.27 $6,249 D/D 1,911 50,225 2.81     -
   Milby Randy Chief Executive Officer   •       •      –    2015-01-30 4 B $3.10 $6,250 D/D 2,016 48,314 2.81     -
   Milby Randy Chief Executive Officer   •       •      –    2014-12-31 4 B $1.91 $6,250 D/D 3,272 46,298 2.81     -

  260 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 8 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed